News Conference News SCAI 2024 No Sex-Specific Differences in PAD Therapy Outcomes: REVIVE Analysis L.A. McKeown May 10, 2024
News Conference News SCAI 2023 SPIRIT 48: Long DES for Diffuse CAD Highly Deliverable, Safe at 1 Year L.A. McKeown May 31, 2023
News Conference News SCAI 2023 Repeat Revascularization Not Increased With Solo Ticagrelor: TWILIGHT Analysis L.A. McKeown May 22, 2023
News Conference News SCAI 2021 ISCHEMIA: PCI/CABG Has Early Hospitalization ‘Tax’ but Equals Meds Later Michael O'Riordan May 06, 2021
News Conference News SCAI 2019 Antithrombotic Use, Risk Perception, Varies Widely for PCI Patients With A-fib Yael L. Maxwell May 24, 2019
Presentation SCAI 2018 PERSPECTIVE Trial: Percutaneous Revascularization at Piedmont for Chronic Total Occlusions Survey Presenter: David E. Kandzari April 28, 2018
News Conference News SCAI 2018 PERSPECTIVE: Contemporary Technique and Practice Confer Clinical Success and QoL Benefit for CTO PCI L.A. McKeown April 26, 2018
News Conference News SCAI 2018 ORBITA Continues to Surprise: 85% of Sham Arm Opted for PCI When Trial Ended L.A. McKeown April 26, 2018